Applying a stringent criterion for long-term survival (>5 years) a large database analysis performed in France has identified both clinical and molecular factors associated with the long-term survival of patients with glioblastoma (GB).
Applying a stringent criterion for long-term survival (>5 years) a large database analysis performed in France has identified both clinical and molecular factors associated with the long-term survival of patients with glioblastoma (GB).